Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study

Autor: Stein, Dan J., Ahokas, Antti, Jarema, Marek, Avedisova, Alla S., Vavrusova, Livia, Chaban, Oleg, Gruget, Céline, Olivier, Valérie, Picarel-Blanchot, Françoise, de Bodinat, Christian
Zdroj: In European Neuropsychopharmacology May 2017 27(5):526-537
Databáze: ScienceDirect